Authors
- Ramy Samargandi, From the Department of Orthopedic Surgery and Traumatology (Samargandi, Bernard, Le Nail); from the Department of pathology (Miquelestorena-Standley), Tours Regional University Hospital, Tours, France, and from the Department of Orthopedic Surgery (Samargandi), Faculty of Medicine, University of Jeddah, Jeddah, Kingdom of Saudi Arabia.
- Mathilde Bernard, From the Department of Orthopedic Surgery and Traumatology (Samargandi, Bernard, Le Nail); from the Department of pathology (Miquelestorena-Standley), Tours Regional University Hospital, Tours, France, and from the Department of Orthopedic Surgery (Samargandi), Faculty of Medicine, University of Jeddah, Jeddah, Kingdom of Saudi Arabia.
- Elodie Miquelestorena-Standley, From the Department of Orthopedic Surgery and Traumatology (Samargandi, Bernard, Le Nail); from the Department of pathology (Miquelestorena-Standley), Tours Regional University Hospital, Tours, France, and from the Department of Orthopedic Surgery (Samargandi), Faculty of Medicine, University of Jeddah, Jeddah, Kingdom of Saudi Arabia.
Abstract
Chondroblastoma is a rare benign cartilaginous tumor that accounts for approximately 1% of bone tumors, but it can be associated with lung metastasis in extremely rare cases, leading to a poor prognosis and death. Herein, we report the case of a 19-year-old male patient who presented with an aggressive chondroblastoma of the proximal humerus and bilateral lung metastasis. The patient was treated with wide local resection, partial metastasectomy, and denosumab. Denosumab treatment was effective in controlling metastatic progression and preventing local recurrence.
Recommended Citation
Samargandi, Ramy; Bernard, Mathilde; and Miquelestorena-Standley, Elodie
(2024)
"Efficacy of denosumab treatment for lung metastasis secondary to proximal humerus chondroblastoma,"
Saudi Medical Journal: Vol. 45:
Iss.
6, Article 13.
DOI: https://doi.org/10.15537/smj.2024.45.6.20230720
DOWNLOADS
Since April 09, 2026
COinS
